Adding Isatuximab to Standard RVD May Improve Outcomes for Myeloma Patients | Elias Mai, MD |

  Рет қаралды 43

HealthTree Foundation for Multiple Myeloma

HealthTree Foundation for Multiple Myeloma

Күн бұрын

Пікірлер
Gamma Secretase Inhibition May Boost CAR-T Effectiveness in Some Myeloma | Andrew Portugese | #ASH24
10:00
How Side Effect Severity Influences Patient Treatment Choice in Multiple Myeloma - Dr. Hydren #ASH24
17:13
HealthTree Foundation for Multiple Myeloma
Рет қаралды 203
Quando eu quero Sushi (sem desperdiçar) 🍣
00:26
Los Wagners
Рет қаралды 15 МЛН
VIP ACCESS
00:47
Natan por Aí
Рет қаралды 30 МЛН
New Myeloma Combinations Using CELMoD’s and Antibody Drug Conjugates | Paul Richardson, MD | #ASH24
6:37
Boosting Infection Protection in Myeloma Patients with IvIG Therapy | Betsy O’Donnell,  MD | #ASH24
3:45
HealthTree Foundation for Multiple Myeloma
Рет қаралды 208
Furthering Our Understanding of Delayed Neurotoxicity after CAR-T in Myeloma | Anupama Kumar |#ASH24
6:21
KRd vs RD: Reducing Progression in High-Risk Smoldering Myeloma | Annemiek Broijl, MD | #ASH24
7:09
HealthTree Foundation for Multiple Myeloma
Рет қаралды 5
Inobrodib in Combination with Pomalidomide and Dexamethasone in Myeloma | Emma Searle, MD | #ASH24
3:35
HealthTree Foundation for Multiple Myeloma
Рет қаралды 11
Ethnicity's Impact on Myeloma Outcomes After Stem Cell Transplant | Frances Cervoni, MD | #ASH24
5:22
HealthTree Foundation for Multiple Myeloma
Рет қаралды 117
Beating T-Cell Exhaustion: The Future of Myeloma Care | Marta Chesi & Erin Meermeier | #ASH24
6:07
HealthTree Foundation for Multiple Myeloma
Рет қаралды 297
Vitamin D DANGERS (Must Know)
6:06
Dr. Eric Berg DC
Рет қаралды 83 М.
Side Effect Severity & Decision-Making Autonomy in Myeloma | Jay Hydren, PhD, CSCS | #ASH24
11:09
HealthTree Foundation for Multiple Myeloma
Рет қаралды 2
Quando eu quero Sushi (sem desperdiçar) 🍣
00:26
Los Wagners
Рет қаралды 15 МЛН